ctrl K

Advertisement

Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

1.03

0.00 (0.00%)

At close: Apr 29, 2025, 3:34 PM

Clearmind Medicine Income Statement

Financials in USD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	26.7K	56.34K	113.38K	2.57K	n/a	n/a	n/a	n/a
Gross Profit	-26.7K	-56.34K	-113.38K	-2.57K	n/a	n/a	n/a	n/a
Operating Income	-6.3M	-8.74M	-8.53M	-3.45M	-233.22K	-105.28K	-254.53K	-6.67K
Interest Income	271.22K	57.97K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-4.88M	-11.93M	-9.37M	-3.9M	-233.22K	-105.28K	-194.53K	-6.67K
Net Income	-5.25M	-11.96M	-9.41M	-4.12M	-233.22K	-105.28K	-194.53K	-6.67K
Selling & General & Admin	4.35M	6.6M	5.43M	3.03M	233.22K	105.28K	254.53K	6.67K
Research & Development	1.38M	2.14M	2.98M	646.49K	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	113.38K	n/a	n/a	n/a	60K	n/a
Operating Expenses	5.72M	8.74M	8.53M	3.68M	233.22K	105.28K	254.53K	6.67K
Interest Expense	36.16K	n/a	19.68K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.57M	8.74M	8.53M	3.68M	233.22K	105.28K	254.53K	6.67K
Income Tax Expense	377.97K	24.09K	40.75K	223.22K	-385.99K	-171.86K	-60K	n/a
Shares Outstanding (Basic)	4.27M	2.02M	433.34K	309.11K	181.3K	123.33K	107.79K	122.22K
Shares Outstanding (Diluted)	4.27M	2.02M	433.34K	309.11K	181.3K	123.33K	107.79K	122.22K
EPS (Basic)	-1.7	-42.58	-168.61	-95.67	-9.56	-6.42	-14.02	-0.42
EPS (Diluted)	-1.7	-42.58	-168.61	-95.67	-9.56	-6.42	-14.02	-0.42
EBITDA	-5.85M	-8.71M	-8.49M	-3.67M	-233.22K	n/a	-56.27K	-6.67K
EBIT	n/a	-8.74M	-8.52M	-3.69M	-412.91K	-86K	-217.41K	-26.68K
Depreciation & Amortization	51.07K	30.69K	113.38K	2.57K	179.69K	86K	161.14K	n/a